Patent details

EP1894562 Title: Pharmaceutical compositions comprising an opioid antagonist

Basic Information

Publication number:
EP1894562
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP071215743
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical compositions comprising an opioid antagonist
French Title of Invention:
Compositions pharmaceutiques comprenant un antagoniste des récepteurs opiacés
German Title of Invention:
Pharmazeutische Zusammensetzungen enthaltend einen Opioidantagonisten
SPC Number:

Dates

Filing date:
15/08/2003
Grant date:
15/12/2010
EP Publication Date:
15/12/2010
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/03/2008
EP B1 Publication Date:
15/12/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/08/2018
Expiration date:
15/08/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/08/2003
 
 

Name:
EURO-CELTIQUE S.A.
Address:
2, avenue Charles de Gaulle, 1653 Luxembourg, Luxembourg (LU)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
15/12/2010
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Machonis Meredith
Address:
United States (US)

2

Name:
Oshlack Benjamin
Address:
United States (US)

3

Name:
Huang Hua-Pin
Address:
United States (US)

4

Name:
Gullapalli Rampurna
Address:
United States (US)

Priority

Priority Number:
403711 P
Priority Date:
15/08/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/50;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
21/07/2017
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
31/12/2018 Outgoing Correspondence 1